The goal of this clinical trial is to pilot and evaluate a human-centered injury thrivorship pathway in injury survivors. The main question it aims to answer is: • Is the pathway appropriate, acceptable, and feasible to meet the medical and social needs of injury survivors? Injury survivors will be purposively sampled to enroll in the pathway and asked to participate in in-depth interviews and their use of pathway resources will be tracked.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
25
Enrollment in the human-centered injury thrivorship pathway.
Zuckerberg San Francisco General Hospital
San Francisco, California, United States
Early Implementation Outcomes - Acceptability, Appropriateness, Feasibility
Early implementation outcomes will be assessed via purposive sampling of pathway participants, their caregivers, and trauma care stakeholders for in-depth semi-structured interviews. "Acceptability is the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Appropriateness is the perceived fit, relevance, or compatibility of the innovation or evidence based practice for a given practice setting, provider, or consumer; and/or perceived fit of the innovation to address a particular issue or problem. Feasibility is defined as the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting."
Time frame: 8-12 weeks post-pathway enrollment
Participant pathway resource utilization - type
Participant engagement with applicable pathway resources will be tracked by type of resource(s) accessed
Time frame: 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year
Participant pathway resource utilization - frequency
Participant engagement with applicable pathway resources will be tracked by frequency of use of the resource(s)
Time frame: 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year
Participant pathway resource utilization - duration
Participant engagement with applicable pathway resources will be tracked by duration of use of the resource(s)
Time frame: 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year
Participant pathway resource utilization - % utilized
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Participant engagement with applicable pathway resources will be tracked by overall % of resources utilized out of resource(s) offered
Time frame: 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year